Clinical implications of E-cadherin associated hereditary diffuse gastric cancer.
Level V
Where this comes from
- Record sourced from PubMed, PMID 15138199.
- Also identified by PMC identifier 1774077.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Approximately 1-3% of gastric cancers arise as a result of inherited gastric cancer predisposition syndromes. These may be of the diffuse or intestinal type. Linkage analysis has recently implicated E-cadherin mutations in an estimated 25% of families with an autosomal dominant predisposition to diffuse type gastric cancers. This subset of gastric cancer has been termed hereditary diffuse gastric cancer (HDGC).
Medical subject headings
- Cadherins
- Mutation
- Stomach Neoplasms